Pandorum Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $10.6M

  • Investors
  • 26

Pandorum General Information

Description

Developer of functional human tissues designed for tissue engineering and regenerative medicine. The company's experimental-stage human liver tissue is created using three-dimensional printing technology and acts as an artificial liver during liver failures or liver transplantation and takes less time to regenerate, enabling surgeons to assure painless liver surgeries.

Contact Information

Website
pandorum.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • EGF 5, Bangalore Bioinnovation Centre
  • Bangalore Helix Biotech Park, Electronics City Phase 1
  • Bengaluru, Karnataka 560100
  • India
+91 098000 00000
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • EGF 5, Bangalore Bioinnovation Centre
  • Bangalore Helix Biotech Park, Electronics City Phase 1
  • Bengaluru, Karnataka 560100
  • India
+91 098000 00000

Pandorum Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pandorum Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 15-Mar-2024 $10.6M 000.00 000.00 Completed Generating Revenue
11. Accelerator/Incubator 14-Oct-2022 000.00 Completed Generating Revenue
10. Later Stage VC 20-Oct-2021 00.000 000.00 000.00 Completed Generating Revenue
9. Later Stage VC (Series B) 08-Sep-2020 00.000 00.00 000.00 Completed Generating Revenue
8. Later Stage VC (Series A) 13-Feb-2018 00.000 00.000 000.00 Completed Product Development
7. Angel (individual) 24-Dec-2016 00000 00000 00.000 Completed Startup
6. Grant 01-Jan-2014 00000 Completed Startup
5. Grant 01-Jan-2012 00000 00000 Completed Startup
4. Angel (individual) $400K $450K Completed Startup
3. Accelerator/Incubator $50K Completed Startup
To view Pandorum’s complete valuation and funding history, request access »

Pandorum Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 CCPS 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Series A1 CCPS 00,000 00.000000 0000.00 0000.00 00 0000.00 00.00
Ordinary Shares 000 00.000000 0000.00 0000.00 00 0000.00 0.000
Preferance Shares 00,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Preferance Shares 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Preferance Shares 36,457 $14.199461 $72.14 $72.14 1x $72.14 14.14%
Ordinary Shares 8,702 $0.012064 $27.72 $27.72 1x $27.72 3.37%
To view Pandorum’s complete cap table history, request access »

Pandorum Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of functional human tissues designed for tissue engineering and regenerative medicine. The company's experimen
Biotechnology
Bengaluru, India
37 As of 2024
000.00
000.00 0000-00-00
0000000000 0 000.00

000000

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor i
0000000000000
San Diego, CA
00 As of 0000
0000
00000000 0000

000000

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
0000000000000
Vancouver, Canada
000 As of 0000
000.00
0000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pandorum Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Organovo Formerly VC-backed San Diego, CA 00 0000 00000000 0000
Aspect Biosystems Venture Capital-Backed Vancouver, Canada 000 000.00 0000000000 000.00
Synthecon Accelerator/Incubator Backed Houston, TX 00 0000000000
Cerapedics Venture Capital-Backed Westminster, CO 000 00000 000000000 00000
InSphero Venture Capital-Backed Schlieren, Switzerland 00 000.00 0000000000 0 000.00
You’re viewing 5 of 7 competitors. Get the full list »

Pandorum Patents

Pandorum Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4384601-A1 Methods for culturing mesenchymal stem cells, compositions and implementations thereof Pending 11-Aug-2021 0000000000
JP-2024530048-A Methods, compositions and their implementation for culturing mesenchymal stem cells - patents.com Pending 11-Aug-2021 0000000000
AU-2020320220-A1 Bioengineered formulation, process for preparing and implementations thereof Inactive 26-Jul-2019 0000000000
GB-2604239-A Bioengineered formulation, process for preparing and implementations thereof Pending 26-Jul-2019 0000000000 0
GB-202202474-D0 Bioengineered formulation, process for preparing and implementations thereof Pending 26-Jul-2019 A61F2/142
To view Pandorum’s complete patent history, request access »

Pandorum Executive Team (5)

Name Title Board Seat
Tuhin Bhowmick Ph.D Co-Founder, Chief Executive Officer & Board Member
Arun Chandru Ph.D Co-Founder, Chief Technology Officer & Board Member
Phani Karra Director of Finance
Satish Nadig Ph.D Chief Medical Advisor
You’re viewing 4 of 5 executive team members. Get the full list »

Pandorum Board Members (6)

Name Representing Role Since
Arun Chandru Ph.D Pandorum Co-Founder, Chief Technology Officer & Board Member 000 0000
Manish Belmannu Self Board Member 000 0000
Sailesh Tulshan 021 Capital Board Member 000 0000
Sonal Asthana Self Board Member 000 0000
Sudipta Gautam Indian Angel Network Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Pandorum Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pandorum Investors (26)

Investor Name Investor Type Holding Investor Since Participating Rounds
Acebright Corporation Minority 000 0000 000000 0
Ashish Kacholia Angel (individual) Minority 000 0000 000000 0
Bandana Kankani Angel (individual) Minority 000 0000 000000 0
Equipact Advisory Venture Capital Minority 000 0000 000000 0
Everest Finance and Investment Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 26 investors. Get the full list »

Pandorum FAQs

  • When was Pandorum founded?

    Pandorum was founded in 2009.

  • Who is the founder of Pandorum?

    Tuhin Bhowmick Ph.D and Arun Chandru Ph.D are the founders of Pandorum.

  • Who is the CEO of Pandorum?

    Tuhin Bhowmick Ph.D is the CEO of Pandorum.

  • Where is Pandorum headquartered?

    Pandorum is headquartered in Bengaluru, India.

  • What is the size of Pandorum?

    Pandorum has 37 total employees.

  • What industry is Pandorum in?

    Pandorum’s primary industry is Biotechnology.

  • Is Pandorum a private or public company?

    Pandorum is a Private company.

  • What is the current valuation of Pandorum?

    The current valuation of Pandorum is 000.00.

  • What is Pandorum’s current revenue?

    The current revenue for Pandorum is 00000.

  • How much funding has Pandorum raised over time?

    Pandorum has raised $25.7M.

  • Who are Pandorum’s investors?

    Acebright, Ashish Kacholia, Bandana Kankani, Equipact Advisory, and Everest Finance and Investment are 5 of 26 investors who have invested in Pandorum.

  • Who are Pandorum’s competitors?

    Organovo, Aspect Biosystems, Synthecon, Cerapedics, and InSphero are some of the 7 competitors of Pandorum.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »